Skip to main content

Advertisement

Log in

Evaluation of Hepatic Function in Liver Cirrhosis (Clinical Utility of Galactose Elimination Capacity, Hepatic Clearance of D-Sorbitol, and Laboratory Investigations)

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Assessment of hepatic function is based on bothliver blood tests and functional tests, the extensiveapplication of which is still controversial. The aim ofthis study was to evaluate the clinical utility of a few selected tests as discriminatory andprognostic indexes: serum albumin, pseudocholinesterase,prothrombin time, as well as galactose eliminationcapacity and hepatic sorbitol clearance. Two separate studies were performed: Study I to investigatehow well these tests assessed severity, and Study II toevaluate their prognostic value. A total of 128consecutive cirrhotic patients classified according to the Child-Pugh score were included in StudyI; Study II was carried out on 47 of these 128 during atwo-year follow-up period. Pairwise correlations betweenall tests and Child-Pugh score yielded higher significant values for liver blood tests thanfor the functional ones. In Study I functional testssuch as galactose elimination capacity and hepaticsorbitol clearance did not appear to be better than conventional biochemical tests indiscriminating clinical severity of cirrhotic patients,as defined by Child-Pugh classification. Results ofStudy II confirmed that in severe liver cirrhosisChildPugh score remains the best method for medium- andlong-term prognosis and for planning livertransplantation. Functional tests should be reserved fordefining the residual functioning liver mass or forstudies about functional liver plasma flow.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Christensen E: Prognostic models in chronic liver disease: Validity, use fulness and future role. J Hepatol 26:1414-1424, 1997

    Google Scholar 

  2. McIntyre N: The limitations of conventional liver function tests. Semin Liver Dis 3:265-274, 1983

    Google Scholar 

  3. Branch RA: Drugs as indicators of hepatic function. Hepatology 2:97-105, 1982

    Google Scholar 

  4. Rothschild MA, Oratz M, Schreiber SS: Serum albumin. Hepatology 8:385-401, 1988

    Google Scholar 

  5. Gluud C, Henriksen JH, Nielsen G: Prognostic indicators in alcoholic cirrhotic men. Hepatology 8:222-227, 1988

    Google Scholar 

  6. Albers I, Hartmann H, Bircher J, Creutzfeldt W: Superiority of the Child-Pugh classification to quantitative liver function tests in assessing prognosis of liver cirrhosis. Scand J Gastroenterol 24:269-276, 1989

    Google Scholar 

  7. Spector I, Corn M: Laboratory tests of hemostasis. The relation to hemorrhage in liver disease. Arch Intern Med 119:577-82, 1967

    Google Scholar 

  8. Christensen E, Schlichting P, Fauerholdt L, Juhl E, Poulsen H, Tygstrup N: Changes of laboratory variables with time in cirrhosis. Prognostic and therapeutic significance. Hepatology 3:843-853, 1985

    Google Scholar 

  9. Tygstrup N. The galactose elimination capacity in control subjects and in patients with cirrhosis of the liver. Acta Med Scand 175:281-289, 1964

    Google Scholar 

  10. Tygstrup N, Winkler K: Kinetics of galactose elimination. Acta Physiol Scand 32:354-362, 1954

    Google Scholar 

  11. Molino G, Cavanna A, Avagnina P, Ballarè M, Torchio M. The hepatic clearance of D-sorbitol: A non-invasive test for evaluating the functional liver plasma flow. Dig Dis Sci 32:753-758, 1987

    Google Scholar 

  12. Winkler K, Keiding S, Tygstrup N: Clearance as a quantitative measure of liver function. In The Liver. Quantitative Aspects of Structure and Function. G Paumgartner, R Preising (eds). 1973, pp 144-155

  13. Molino G, Avagnina P, Cavanna A, Ballarè M, Torchio M, Bona B, Belforte G: Sorbitol clearance: a parameter reflecting liver plasma flow in the rat. Res Commun Chem Pathol Pharmacol 1:119-132, 1986

    Google Scholar 

  14. Zeeh J, Lange H, Bosch J, Pohl S, Loesgen H, Eggers R, Navasa M, Chesta J, Bircher J: Steady state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroente rology 95:749-759, 1988

    Google Scholar 

  15. Molino G, Ballarè M, Torchio M, Niro AG, Aurucci PE, Grosso M, Fava C: Combined evaluation of total and functional plasma flows and intrahepatic shunting. Dig Dis Sci 36:1189-1196, 1991

    Google Scholar 

  16. Molino G, Avagnina P, Belforte G, Bircher J: Assessment of the hepatic circulation in humans: New concepts based on evidence derived from a D-sorbitol clearance method. J Lab Clin Med 131:393-405, 1998

    Google Scholar 

  17. Christensen E, Schlichting P, Fauerholdt L, Gluud C, Andersen PK, Juhl E, Poulsen H, Tygstrup N: Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 4:430-435, 1984

    Google Scholar 

  18. Child CG III, Turcotte JG: Surgery and portal hypertension. In The Liver and Portal Hypertension. CG Child (ed). Philadelphia, Saunders, 1964, pp 1-85

    Google Scholar 

  19. Bergme yer HU, Gruber W, Guttmann I: D-Sorbitol. In Methods of Enzymatic Analysis. HU Bergmeyer (ed). New York, Verlag Chemie, 1975, pp 1323-1330

    Google Scholar 

  20. Cox DR: Regression models and life tables (with discussion). J R Stat (Seri B) 34:187-220, 1972

    Google Scholar 

  21. Salerno F, Borroni G, Moser P, Sangiovanni A, Almasio P, Budillon G, Capuano G, Muraca M, Marchesini G, Bernardi M, Marenco G, Molino G, Rossaro L, Solinas A, Ascione A, AISF Group for the Study of Liver Transplantation: Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. J Hepatol 25:474-480, 1996

    Google Scholar 

  22. Merkel C, Marchesini G, Fabbri A, Bianco S, Bianchi S, Enzo E, Sacerdoti D, Zoli M, Gatta A: The course of galactose elimination capacity in patients with alcoholic cirrhosis: Possible use as a surrogate marker for death. Hepatology 24:820-823, 1996

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garello, E., Battista, S., Bar, F. et al. Evaluation of Hepatic Function in Liver Cirrhosis (Clinical Utility of Galactose Elimination Capacity, Hepatic Clearance of D-Sorbitol, and Laboratory Investigations). Dig Dis Sci 44, 782–788 (1999). https://doi.org/10.1023/A:1026678228967

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026678228967

Navigation